Indian Pharmaceutical Market
- All
- News
- Videos
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Trump's 50% Tariffs Unlikely To Significantly Impact India's Growth: Analysts
As the deadline for US secondary tariffs of 25 per cent falls this week over Russian oil purchase, analysts say that a total of 50 per cent tariff is unlikely to significantly impact India's growth due to a robust domestic demand.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Moscow Says India May Replace West In Russian Pharmaceuticals Market: Report
Indian pharmaceutical companies may replace Western manufacturers leaving the Russian market, Russian envoy to India Denis Alipov said on Friday.
-
China To Provide "Greater Access" To Indian Anti-Cancer Drugs After Movie
China on Monday said it has initiated specific measures for the import of Indian pharmaceuticals, specially anti-cancer medicines, to provide them "greater access" to the Chinese market, days after a Chinese movie on a leukaemia patient highlighted the need for paving the way for import of cheap Indian medicines.
-
China Should Give More Market Access For Indian Products: President
Seeking a "more equitable" bilateral trade, India today sought from China greater market for its products like drugs and pharmaceuticals, IT and IT-related services and agro-products.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Trump's 50% Tariffs Unlikely To Significantly Impact India's Growth: Analysts
As the deadline for US secondary tariffs of 25 per cent falls this week over Russian oil purchase, analysts say that a total of 50 per cent tariff is unlikely to significantly impact India's growth due to a robust domestic demand.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Moscow Says India May Replace West In Russian Pharmaceuticals Market: Report
Indian pharmaceutical companies may replace Western manufacturers leaving the Russian market, Russian envoy to India Denis Alipov said on Friday.
-
China To Provide "Greater Access" To Indian Anti-Cancer Drugs After Movie
China on Monday said it has initiated specific measures for the import of Indian pharmaceuticals, specially anti-cancer medicines, to provide them "greater access" to the Chinese market, days after a Chinese movie on a leukaemia patient highlighted the need for paving the way for import of cheap Indian medicines.
-
China Should Give More Market Access For Indian Products: President
Seeking a "more equitable" bilateral trade, India today sought from China greater market for its products like drugs and pharmaceuticals, IT and IT-related services and agro-products.
